ArticleFrontiers in public health2025
Multicenter epidemiological distribution, pathogens, and drug-resistance characteristics of chronic osteomyelitis in Central China.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge, attitude, and practice of patients with osteomyelitis: a cross-sectional study using structural equation modeling.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The incidence of chronic osteomyelitis increases annually. Currently, epidemiological data on chronic osteomyelitis in Central China are scarce. Describing the epidemiological distribution, pathogens, and drug resistance characteristics of patients with chronic osteomyelitis in Central China is critical for its prevention and control. In this study, we aimed to statistically analyze patients with chronic osteomyelitis from four local hospitals to provide a reference for prevention and control in this region. Methods: We conducted a retrospective analysis of the clinical data of patients with chronic osteomyelitis admitted to four hospitals in Central China between January 1, 2016, and December 31, 2021, using ICD codes in the electronic medical record system. Data extracted included patients' basic details, hospitalization records, infection status, and bacterial culture results. Statistical descriptions included pathogen detection, distribution, and changes. Furthermore, we analyzed the antibiotic resistance of Gram-positive and -negative bacteria. Patients with positive cultures underwent risk-factor analysis. Results: We included 632 patients with chronic osteomyelitis, comprising traumatic osteomyelitis (464 patients), hematogenous osteomyelitis (120 patients), and diabetic foot osteomyelitis (48 patients). The median age was 46 (IQR 30-58) years, and the majority were aged between 41 and 60 years. The male-to-female ratio was 2.49:1. Traffic accidents were identified as the primary etiological factor. The three most commonly affected sites were the tibia, femur, and calcaneus. Among the laboratory indicators, the erythrocyte sedimentation rate had the highest positive rate at 57.71%. Bacterial cultures were performed on the intraoperative specimens of 421 patients and yielded 292 positives (69.36%), of which we identified 386 isolates from 74 pathogens. The most prevalent pathogen were Conclusion: Chronic osteomyelitis predominantly affects middle-aged and older adults, males, and those with tibial injuries from traffic accidents requiring special attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.